Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

[1]  R. Wells.  Induction therapy for adults with acute lymphoblastic leukemia , 2006, Current oncology reports.

[2]  F. Aversa,et al.  Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options , 2006, Bone Marrow Transplantation.

[3]  J. Klein,et al.  Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research , 2006, British journal of haematology.

[4]  H. Dombret,et al.  Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials , 2006, Leukemia.

[5]  G. Cho,et al.  Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia , 2005, Bone Marrow Transplantation.

[6]  K. Cornetta,et al.  Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Béné,et al.  Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. , 2004, Blood.

[8]  H. Dombret,et al.  Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Harriet Noreen,et al.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.

[10]  V. Diehl,et al.  Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Heimfeld,et al.  HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. , 2003, Blood.

[12]  S. Singhal,et al.  The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. , 2002, Blood.

[13]  Todd E DeFor,et al.  Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  J. Klein,et al.  Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  C. Craddock,et al.  Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. , 2002, Blood.

[16]  J. Hansen,et al.  Trends in transplantation of hematopoietic stem cells from unrelated donors. , 2001, Current opinion in hematology.

[17]  B. Löwenberg,et al.  Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. , 2001, Blood.

[18]  D. Monos,et al.  Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. , 2001, Tissue antigens.

[19]  R. Larson.  Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. , 2000, Hematology/oncology clinics of North America.

[20]  Terry L. Smith,et al.  Primary refractory and relapsed adult acute lymphoblastic leukemia , 1999, Cancer.

[21]  M. Horowitz,et al.  Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. , 1998, Leukemia research.

[22]  M. Tanimoto,et al.  Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission , 1998, Bone Marrow Transplantation.

[23]  S. Sallan,et al.  Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. , 1997, Blood.

[24]  F. Mandelli,et al.  Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R‐87 protocol , 1997, British journal of haematology.

[25]  M. Labopin,et al.  Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis , 1997, Bone Marrow Transplantation.

[26]  H. Lazarus,et al.  Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG) , 1997, Bone Marrow Transplantation.

[27]  E. Thiel,et al.  Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation , 1995, Annals of Internal Medicine.

[28]  S. Feig,et al.  Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors , 1994, British journal of haematology.

[29]  F. Appelbaum,et al.  Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. , 1994, Blood.

[30]  W. Woods,et al.  Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome , 1994, British journal of haematology.

[31]  S. Piantadosi,et al.  Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Hernández-Rivas,et al.  Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. , 2005, Haematologica.

[33]  M. Vignetti,et al.  GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. , 2004, Haematologica.

[34]  J. Sierra,et al.  Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. , 2003, Haematologica.

[35]  K. Sepkowitz,et al.  Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. , 2001, Hematology. American Society of Hematology. Education Program.

[36]  D. Confer,et al.  The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation. , 1999, Clinical transplants.

[37]  A. Nademanee,et al.  Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. , 1991, Blood.

[38]  H. Prentice,et al.  Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. , 1989, Leukemia.